<DOC>
	<DOCNO>NCT01608698</DOCNO>
	<brief_summary>The purpose study evaluate different side effect contraceptive use two oral combine contraceptive pill ( OCP ) combination 30 mcg ethinylestradiol/2 mg chlormadinone acetate ( Belara速 ) 30 mcg ethinylestradiol/3 mg drospirenone ( Yasmin速 ) , especially body weight change .</brief_summary>
	<brief_title>Comparison Body Weight Change During Contraception With Belara Yasmin</brief_title>
	<detailed_description>Oral combine contraceptive pill ( OCP ) contraceptive use reproductive woman . The various type progestin OCP give various effect either benefit ( non-contraceptive benefit ) side effect . These effect depend pharmacological activity progestin . Many study show cause discontinuation use OCP , increase body weight , androgenic effect vaginal spotting . OCP combination 30 mcg ethinylestradiol/2 mg chlormadinone acetate ( Belara速 ) 30 mcg ethinylestradiol/3 mg drospirenone ( Yasmin速 ) common use practice . The type progestin ( chlormadinone drospirenone ) might effect different outcome woman especially body weight change use . Chlormadinone C-21 progestin glucocorticoid antiandrogenic effect . Drospirenone progestin spironolactone derivative antimineralocorticoid antiandrogenic effect . Both progestin might less effect body weight change provide non-contraceptive benefit . So investigator want study different effect progestin two type OCP . The result study could give information choose proper OCP reproductive woman .</detailed_description>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Body Weight Changes</mesh_term>
	<mesh_term>Drospirenone</mesh_term>
	<mesh_term>Chlormadinone Acetate</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Drospirenone ethinyl estradiol combination</mesh_term>
	<criteria>Reproductive woman Woman BMI &lt; 28.5 kg/m2 . Woman regular menstruation . Woman n't pelvic organ disorder . Woman want contraception oral contraceptive pill . Woman abnormal blood pressure Woman abnormal vaginal bleeding Pregnant woman Woman medication effect contraceptive pill , antifungal , antiretroviral , anticonvulsant drug . Woman contraindication OCP . Woman use steroid 3 month period enrollment study . Smoking Woman eat habit disorder .</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>chlormadinone acetate</keyword>
	<keyword>drospirenone</keyword>
	<keyword>contraceptive pill</keyword>
</DOC>